Search research articles
Contact Us
Filters
Showing results (81-90 of 183) with videos related to
Page
of 19
Sort By:
Pakistan Journal of Pharmaceutical Sciences
|
March 5, 2013
Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere
Liang Ye, Fenghua Fu, Wanhui Liu, et al.
European Journal of Pharmacology
|
January 2, 2013
SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways
Guangying Du, Haibo Zhu, Pengfei Yu, et al.
Frontiers in Pharmacology
|
March 11, 2026
TAAR1-mediated pathways regulating nigrostriatal function and the discovery and pharmacological characterization of a novel TAAR1 agonist, Selutaront
Jianzhao Zhang, Xuan Deng, Jiawei Lv, et al.
Frontiers in Pharmacology
|
October 1, 2021
Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor
Haibo Zhu, Wenyan Wang, Chunjie Sha, et al.
European Journal of Medicinal Chemistry
|
September 11, 2019
Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance
Mengqi Guo, Qianwen Ren, Binghua Wang, et al.
Molecular Medicine Reports
|
January 8, 2013
Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation
Hongbo Wang, Guang Cheng, Yuan Du, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 21, 2023
Anti-Colorectal Cancer Effects of a Novel Camptothecin Derivative PCC0208037 <i>In Vitro</i> and <i>In Vivo</i>
Min Li, Linxu Wang, Yingjie Wei, et al.
Planta Medica
|
June 13, 2003
Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies
Haibo Zhu, Zhenhua Wang, Chengjun Ma, et al.
Future Medicinal Chemistry
|
May 31, 2022
9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitors
Wenyan Wang, Shilan Lin, Guangying Du, et al.
Frontiers in Pharmacology
|
April 28, 2022
LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
Jiahao Qiu, Xinfa Bai, Wenjing Zhang, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 183) with videos related to
Sort By:
Page
of 19
Pakistan Journal of Pharmaceutical Sciences
|
March 5, 2013
Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere
Liang Ye, Fenghua Fu, Wanhui Liu, et al.
European Journal of Pharmacology
|
January 2, 2013
SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways
Guangying Du, Haibo Zhu, Pengfei Yu, et al.
Frontiers in Pharmacology
|
March 11, 2026
TAAR1-mediated pathways regulating nigrostriatal function and the discovery and pharmacological characterization of a novel TAAR1 agonist, Selutaront
Jianzhao Zhang, Xuan Deng, Jiawei Lv, et al.
Frontiers in Pharmacology
|
October 1, 2021
Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor
Haibo Zhu, Wenyan Wang, Chunjie Sha, et al.
European Journal of Medicinal Chemistry
|
September 11, 2019
Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance
Mengqi Guo, Qianwen Ren, Binghua Wang, et al.
Molecular Medicine Reports
|
January 8, 2013
Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation
Hongbo Wang, Guang Cheng, Yuan Du, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 21, 2023
Anti-Colorectal Cancer Effects of a Novel Camptothecin Derivative PCC0208037 <i>In Vitro</i> and <i>In Vivo</i>
Min Li, Linxu Wang, Yingjie Wei, et al.
Planta Medica
|
June 13, 2003
Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies
Haibo Zhu, Zhenhua Wang, Chengjun Ma, et al.
Future Medicinal Chemistry
|
May 31, 2022
9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitors
Wenyan Wang, Shilan Lin, Guangying Du, et al.
Frontiers in Pharmacology
|
April 28, 2022
LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer
Jiahao Qiu, Xinfa Bai, Wenjing Zhang, et al.
Page
of 19